Clinical Trials Logo
  1. Home
  2. Cervical Cancer
  3. NCT05635123
  4. Details
NCT05635123 Clinical Trial

A Cohort Study of Uterine Malignancies

Cervical Cancer Clinical Trial

Official title:
A Cohort Study of Uterine Malignancies

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05635123
Other study ID # IRB-20220352-R
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 15, 2023
Est. completion date December 1, 2030

Study information
Verified date October 2023
Source Women's Hospital School Of Medicine Zhejiang University
Contact Hui Wang, PhD
Phone 0571-89998857
Email wang71hui@zju.deu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.

Description:

After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.

Recruitment information / eligibility
Status Recruiting
Enrollment 6200
Est. completion date December 1, 2030
Est. primary completion date December 1, 2025
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria: - Age 20-75 years; - Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time; - Women attending a health check-up; - Obtain informed consent and sign an informed consent form. Exclusion Criteria: - Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment; - Patients with cancer other than cervical cancer or endometrial cancer; - Women who have received hysterectomy or pelvic radiation therapy previously.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• No intervention
This is a prospective observational study with no intervention.

Locations
Country Name City State
China Women's hospital school of medicine zhejiang university Hangzhou Zhejiang

Sponsors (1)
Lead Sponsor Collaborator
Women's Hospital School Of Medicine Zhejiang University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary progression free survival (PFS) progression free survival for patients with cervical cancer or endometrial cancer 60 months
See also
  Status Clinical Trial Phase
Recruiting NCT06223308 - A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors Phase 1/Phase 2
Terminated NCT03367871 - Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer Phase 2
Active, not recruiting NCT04537156 - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) Phase 3
Recruiting NCT03668639 - Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Phase 2/Phase 3
Active, not recruiting NCT04242199 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors Phase 1
Withdrawn NCT04806945 - A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer Phase 3
Active, not recruiting NCT04185389 - Long-Term Follow-Up of HPV FOCAL Participants
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Completed NCT03384511 - The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. Phase 4
Recruiting NCT05107674 - A Study of NX-1607 in Adults With Advanced Malignancies Phase 1
Completed NCT05120167 - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy N/A
Recruiting NCT05483491 - KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer Phase 1
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Completed NCT05862844 - Promise Women Project N/A
Recruiting NCT04934982 - Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2) N/A
Recruiting NCT03876860 - An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis N/A
Completed NCT03652077 - A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies Phase 1
Completed NCT00543543 - Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) Phase 3
Terminated NCT04864782 - QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer Phase 2/Phase 3
Recruiting NCT04226313 - Self-sampling for Non-attenders to Cervical Cancer Screening N/A